APYX
Price
$1.99
Change
-$0.03 (-1.49%)
Updated
Aug 29 closing price
Capitalization
75.26M
67 days until earnings call
EMBC
Price
$14.48
Change
-$0.02 (-0.14%)
Updated
Aug 29 closing price
Capitalization
846.86M
114 days until earnings call
Interact to see
Advertisement

APYX vs EMBC

Header iconAPYX vs EMBC Comparison
Open Charts APYX vs EMBCBanner chart's image
Apyx Medical
Price$1.99
Change-$0.03 (-1.49%)
Volume$17.89K
Capitalization75.26M
Embecta
Price$14.48
Change-$0.02 (-0.14%)
Volume$366.81K
Capitalization846.86M
APYX vs EMBC Comparison Chart in %
Loading...
APYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EMBC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APYX vs. EMBC commentary
Aug 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APYX is a Hold and EMBC is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 31, 2025
Stock price -- (APYX: $1.99 vs. EMBC: $14.48)
Brand notoriety: APYX and EMBC are both not notable
APYX represents the Medical/Nursing Services, while EMBC is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: APYX: 18% vs. EMBC: 59%
Market capitalization -- APYX: $75.26M vs. EMBC: $846.86M
APYX [@Medical/Nursing Services] is valued at $75.26M. EMBC’s [@Pharmaceuticals: Other] market capitalization is $846.86M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $230.89B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.67B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APYX’s FA Score shows that 0 FA rating(s) are green whileEMBC’s FA Score has 2 green FA rating(s).

  • APYX’s FA Score: 0 green, 5 red.
  • EMBC’s FA Score: 2 green, 3 red.
According to our system of comparison, EMBC is a better buy in the long-term than APYX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APYX’s TA Score shows that 1 TA indicator(s) are bullish while EMBC’s TA Score has 6 bullish TA indicator(s).

  • APYX’s TA Score: 1 bullish, 8 bearish.
  • EMBC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, EMBC is a better buy in the short-term than APYX.

Price Growth

APYX (@Medical/Nursing Services) experienced а -4.78% price change this week, while EMBC (@Pharmaceuticals: Other) price change was +1.75% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.77%. For the same industry, the average monthly price growth was +6.45%, and the average quarterly price growth was +9.91%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.93%. For the same industry, the average monthly price growth was +6.00%, and the average quarterly price growth was +26.47%.

Reported Earning Dates

APYX is expected to report earnings on Nov 06, 2025.

EMBC is expected to report earnings on Dec 23, 2025.

Industries' Descriptions

@Medical/Nursing Services (+0.77% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+0.93% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EMBC($847M) has a higher market cap than APYX($75.3M). APYX YTD gains are higher at: 25.949 vs. EMBC (-27.377). EMBC has higher annual earnings (EBITDA): 252M vs. APYX (-10.64M). APYX has less debt than EMBC: APYX (39.1M) vs EMBC (1.55B). EMBC has higher revenues than APYX: EMBC (1.1B) vs APYX (46.5M).
APYXEMBCAPYX / EMBC
Capitalization75.3M847M9%
EBITDA-10.64M252M-4%
Gain YTD25.949-27.377-95%
P/E RatioN/A10.20-
Revenue46.5M1.1B4%
Total Cash29.3MN/A-
Total Debt39.1M1.55B3%
FUNDAMENTALS RATINGS
APYX: Fundamental Ratings
APYX
OUTLOOK RATING
1..100
30
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APYXEMBC
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 9 days ago
87%
Bullish Trend 11 days ago
76%
Declines
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
APYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EMBC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSSCX21.180.03
+0.14%
Columbia Small Cap Value I C
MITDX38.94-0.19
-0.49%
MFS Massachusetts Investors Tr R4
SCUVX28.96-0.17
-0.58%
Hartford Schroders US Small Cap Opps A
IHSFX23.46-0.16
-0.68%
Hartford Small Company F
BRZKX13.18-0.10
-0.75%
BlackRock Sust Aware Adg Intl Eq K

EMBC and

Correlation & Price change

A.I.dvisor indicates that over the last year, EMBC has been loosely correlated with WAT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if EMBC jumps, then WAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EMBC
1D Price
Change %
EMBC100%
+0.91%
WAT - EMBC
37%
Loosely correlated
+1.39%
MTD - EMBC
37%
Loosely correlated
+1.40%
RVTY - EMBC
36%
Loosely correlated
+0.99%
A - EMBC
35%
Loosely correlated
+0.56%
AZTA - EMBC
34%
Loosely correlated
+2.07%
More